Correction: Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness (PLoS ONE (2015) 10, 7 (e0132546) DOI: 10.1371/journal.pone.0132546);Lymphangioleiomyomatosis biomarkers linked to lung metastatic potential and cell stemness

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  De Garibay, Gorka Ruiz ^a   Herranz, Carmen ^a   Llorente, Alicia ^a   Boni, Jacopo ^a   Serra Musach, Jordi ^a   Mateo, Francesca ^a   Aguilar, Helena ^a   Gómez Baldó, Laia ^a   Petit, Anna ^b   Vidal, August ^b   Climent, Fina ^b   Hernández Losa, Javier ^c   Cordero, Álex ^b   González Suárez, Eva ^b   Sánchez Mut, José Vicente ^b   Esteller, Manel ^b,d,e   Llatjós, Roger ^b   Varela, Mar ^b   López, José Ignacio ^f   García, Nadia ^a   Extremera, Ana I ^a   Gumà, Anna ^b   Ortega, Raúl ^b   Plà, María Jesús ^b   Fernández, Adela ^a   Pernas, Sònia ^a   Falo, Catalina ^a   Morilla, Idoia ^a   Campos, Miriam ^a   Gil, Miguel ^a   Román, Antonio ^c   Molina Molina, María ^b,g   Ussetti, Piedad ^h   Laporta, Rosalía ^h   Valenzuela, Claudia ⁱ   Ancochea, Julio ⁱ   Xaubet, Antoni ^g,j   Casanova, Álvaro ^k   Pujana, Miguel Angel ^a   more..

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^f BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^j HOSPITAL CLÍNIC   (Spain)

^k Pozuelo de Alarcón   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; BETA3 INTEGRIN; BIOLOGICAL MARKER; FASCIN; FASCIN 1; INHIBITOR OF DIFFERENTIATION 1; MAMMALIAN TARGET OF RAPAMYCIN; TRANSCRIPTION FACTOR SOX; TUBERIN; UNCLASSIFIED DRUG; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ALDH1 GENE; ANIMAL CELL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EMBRYO; FSCN1 GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ID1 GENE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPHANGIOLEIOMYOMATOSIS; MTORC1 GENE; NONHUMAN; PATHOGENESIS; RAT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEM CELL; TSC1 GENE; TSC2 GENE; TUMOR SUPPRESSOR GENE; BLOOD; BREAST TUMOR; CANCER STEM CELL; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; METASTASIS; PATHOLOGY; SECONDARY;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 84940688735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0207586     Document Type: Erratum

References (70)

1. Blei F Lymphangiomatosis: clinical overview. Lymphat Res Biol. 2011; 9: 185-190. doi: 10.1089/lrb.2011.0020 PMID: 22196283
2. Hohman DW, Noghrehkar D, Ratnayake S Lymphangioleiomyomatosis: A review. Eur J Intern Med. 2008; 19: 319-324. doi: 10.1016/j.ejim.2007.10.015 PMID: 18549932
3. McCormack FX Lymphangioleiomyomatosis: a clinical update. Chest. 2008; 133: 507-516. doi: 10.1378/chest.07-0898 PMID: 18252917
4. Taveira-DaSilva AM, Steagall WK, Moss J Lymphangioleiomyomatosis. Cancer Control. 2006; 13: 276-285. PMID: 17075565
5. Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest. 1999; 115: 1041-1052. PMID: 10208206
6. Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, et al. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med. 2000; 161: 1002-1009. PMID: 10712355
7. Gao L, Yue MM, Davis J, Hyjek E, Schuger L In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor. Virchows Arch. 2014; 464: 495-503. doi: 10.1007/s00428-014-1559-9 PMID: 24570392
8. Yu J, Henske EP mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis. Lymphat Res Biol. 2010; 8: 43-49. doi: 10. 1089/lrb.2009.0020 PMID: 20235886
9. McCormack FX, Travis WD, Colby TV, Henske EP, Moss J Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. Am J Respir Crit Care Med. 2012; 186: 1210-1212. doi: 10.1164/rccm.201205-0848OE PMID: 23250499
10. Muzykewicz DA, Sharma A, Muse V, Numis AL, Rajagopal J, Thiele EA TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex. J Med Genet. 2009; 46: 465-468. doi: 10.1136/jmg.2008.065342 PMID: 19419980
11. Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, et al. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet. 2002; 47: 20-28. PMID: 11829138
12. Carsillo T, Astrinidis A, Henske EP Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000; 97: 6085-6090. PMID: 10823953
13. Astrinidis A, Khare L, Carsillo T, Smolarek T, Au KS, Northrup H, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet. 2000; 37: 55-57. PMID: 10633137
14. Crino PB, Nathanson KL, Henske EP The tuberous sclerosis complex. N Engl J Med. 2006; 355: 1345-1356. PMID: 17005952
15. Zoncu R, Efeyan A, Sabatini DM mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011; 12: 21-35. doi: 10.1038/nrm3025 PMID: 21157483
16. McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011; 364: 1595-1606. doi: 10.1056/NEJMoa1100391 PMID: 21410393
17. Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. Lymphat Res Biol. 2010; 8: 9-19. doi: 10.1089/lrb.2009.0024 PMID: 20235883
18. Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP Jr., Wang JA, Kumaki F, et al. Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2004; 101: 17462-17467. PMID: 15583138
19. Seyama K, Kumasaka T, Kurihara M, Mitani K, Sato T Lymphangioleiomyomatosis: a disease involving the lymphatic system. Lymphat Res Biol. 2010; 8: 21-31. doi: 10.1089/lrb.2009.0018 PMID: 20235884
20. Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med. 2003; 167: 976-982. PMID: 12411287
21. Bittmann I, Rolf B, Amann G, Lohrs U Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol. 2003; 34: 95-98. PMID: 12605373
22. Badri KR, Gao L, Hyjek E, Schuger N, Schuger L, Qin W, et al. Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2013; 187: 663-665. PMID: 23504366
23. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012; 485: 55-61. doi: 10.1038/nature10912 PMID: 22367541
24. Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, et al. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur J Cancer. 2005; 41: 1628-1636. PMID: 15951164
25. Nasr Z, Robert F, Porco JA Jr., Muller WJ, Pelletier J eIF4F suppression in breast cancer affects maintenance and progression. Oncogene. 2013; 32: 861-871. doi: 10.1038/onc.2012.105 PMID: 22484424
26. Pacheco-Rodriguez G, Moss J The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells. Crit Rev Immunol. 2010; 30: 387-394. PMID: 20666708
27. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005; 436: 518-524. PMID: 16049480
28. Landemaine T, Jackson A, Bellahcene A, Rucci N, Sin S, Abad BM, et al. A six-gene signature predicting breast cancer lung metastasis. Cancer Res. 2008; 68: 6092-6099. doi: 10.1158/0008-5472.CAN-08-0436 PMID: 18676831
29. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005; 365: 671-679. PMID: 15721472
30. Kobayashi E, Masuda M, Nakayama R, Ichikawa H, Satow R, Shitashige M, et al. Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma. Mol Cancer Ther. 2010; 9: 535-544. doi: 10.1158/1535-7163.MCT-09-0774 PMID: 20159990
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102: 15545-15550. PMID: 16199517
32. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M KEGG for integration and interpretation of largescale molecular data sets. Nucleic Acids Res. 2012; 40: D109-114. doi: 10.1093/nar/gkr988 PMID: 22080510
33. Ferrer I, Mohan P, Chen H, Castellsague J, Gomez-Baldo L, Carmona M, et al. Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling. J Pathol. 2014; 233: 247-257. doi: 10.1002/path.4343 PMID: 24604753
34. Gomez-Baldo L, Schmidt S, Maxwell CA, Bonifaci N, Gabaldon T, Vidalain PO, et al. TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle. 2010; 9: 1143-1155. PMID: 20237422
35. Anton E, Casanova A, Xaubet A, Roman A, Villena V, Montero MC, et al. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry. Sarcoidosis Vasc Diffuse Lung Dis. 2009; 26: 85-91. PMID: 20560288
36. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008; 68: 3108-3114. doi: 10.1158/0008-5472.CAN-07-5644 PMID: 18451135
37. Hashimoto Y, Kim DJ, Adams JC The roles of fascins in health and disease. J Pathol. 2011; 224: 289-300. doi: 10.1002/path.2894 PMID: 21618240
38. Nishiyama K, Takaji K, Uchijima Y, Kurihara Y, Asano T, Yoshimura M, et al. Protein kinase A-regulated nucleocytoplasmic shuttling of Id1 during angiogenesis. J Biol Chem. 2007; 282: 17200-17209. PMID: 17412691
39. Gan B, Sahin E, Jiang S, Sanchez-Aguilera A, Scott KL, Chin L, et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci U S A. 2008; 105: 19384-19389. doi: 10.1073/pnas.0810584105 PMID: 19052232
40. Ying QL, Nichols J, Chambers I, Smith A BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003; 115: 281-292. PMID: 14636556
41. Romero-Lanman EE, Pavlovic S, Amlani B, Chin Y, Benezra R Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. Stem Cells Dev. 2012; 21: 384-393. doi: 10.1089/scd.2011.0428 PMID: 22013995
42. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007; 1: 555-567. doi: 10.1016/j.stem.2007.08.014 PMID: 18371393
43. Lo PK, Kanojia D, Liu X, Singh UP, Berger FG, Wang Q, et al. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFbeta signaling. Oncogene. 2012; 31: 2614-2626. doi: 10.1038/onc.2011.439 PMID: 21996747
44. Fu N, Lindeman GJ, Visvader JE The mammary stem cell hierarchy. Curr Top Dev Biol. 2014; 107: 133-160. doi: 10.1016/B978-0-12-416022-4.00005-6 PMID: 24439805
45. Chakravarty G, Moroz K, Makridakis NM, Lloyd SA, Galvez SE, Canavello PR, et al. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med (Maywood). 2011; 236: 145-155.
46. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. 2012; 148: 1015-1028. doi: 10.1016/j.cell.2012.02.008 PMID: 22385965
47. Treutlein B, Brownfield DG, Wu AR, Neff NF, Mantalas GL, Espinoza FH, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature. 2014; 509: 371-375. doi: 10.1038/nature13173 PMID: 24739965
48. Honeth G, Schiavinotto T, Vaggi F, Marlow R, Kanno T, Shinomiya I, et al. Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule. Stem Cell Reports. 2015; 4: 699-711. doi: 10.1016/j.stemcr.2015.02.013 PMID: 25818813
49. Boecker W, Moll R, Dervan P, Buerger H, Poremba C, Diallo RI, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol. 2002; 198: 458-467. PMID: 12434415
50. Lin HJ, Hsieh FC, Song H, Lin J Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br J Cancer. 2005; 93: 1372-1381. PMID: 16288304
51. Wagner SN, Wagner C, Schultewolter T, Goos M Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy. Cancer Immunol Immunother. 1997; 44: 239-247. PMID: 9222283
52. Bonetti F, Colombari R, Manfrin E, Zamboni G, Martignoni G, Mombello A, et al. Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. Am J Clin Pathol. 1989; 92: 491-495. PMID: 2552794
53. Steagall WK, Zhang L, Cai X, Pacheco-Rodriguez G, Moss J Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation. Am J Respir Crit Care Med. 2015; 191: 854-856. doi: 10.1164/rccm.201412-2170LE PMID: 25830522
54. Cai X, Pacheco-Rodriguez G, Fan QY, Haughey M, Samsel L, El-Chemaly S, et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2010; 182: 1410-1418. doi: 10.1164/rccm.201003-0489OC PMID: 20639436
55. Delaney SP, Julian LM, Stanford WL The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis. Front Cell Dev Biol. 2014; 2: 69. doi: 10.3389/fcell.2014.00069 PMID: 25505789
56. McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J, et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat. 2011; 129: 37-47. doi: 10.1007/s10549-010-1177-4 PMID: 20859676
57. Li ZD, Hu XW, Wang YT, Fang J Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Lett. 2009; 583: 1999-2003. doi: 10.1016/j.febslet.2009.05.013 PMID: 19447105
58. Mistry H, Hsieh G, Buhrlage SJ, Huang M, Park E, Cuny GD, et al. Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther. 2013; 12: 2651-2662. doi: 10.1158/1535-7163.MCT-13-0103-T PMID: 24130053
59. Soroceanu L, Murase R, Limbad C, Singer E, Allison J, Adrados I, et al. Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target. Cancer Res. 2013; 73: 1559-1569. doi: 10.1158/0008-5472.CAN-12-1943 PMID: 23243024
60. Tobin NP, Harrell JC, Lovrot J, Egyhazi Brage S, Frostvik Stolt M, Carlsson L, et al. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival. Ann Oncol. 2015; 26: 81-88. doi: 10.1093/annonc/mdu498 PMID: 25361981
61. Russell RC, Fang C, Guan KL An emerging role for TOR signaling in mammalian tissue and stem cell physiology. Development. 2011; 138: 3343-3356. doi: 10.1242/dev.058230 PMID: 21791526
62. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A. 2007; 104: 16158-16163. PMID: 17911267
63. Perk J, Iavarone A, Benezra R Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer. 2005; 5: 603-614. PMID: 16034366
64. Hasskarl J, Munger K Id proteins - tumor markers or oncogenes? Cancer Biol Ther. 2002; 1: 91-96. PMID: 12170780
65. Finlay G The LAM cell: what is it, where does it come from, and why does it grow? Am J Physiol Lung Cell Mol Physiol. 2004; 286: L690-693. PMID: 15003933
66. Li C, Lee PS, Sun Y, Gu X, Zhang E, Guo Y, et al. Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med. 2014; 211: 15-28. doi: 10.1084/jem.20131080 PMID: 24395886
67. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-715. doi: 10.1016/j.cell.2008.03.027 PMID: 18485877
68. Valastyan S, Weinberg RA Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147: 275-292. doi: 10.1016/j.cell.2011.09.024 PMID: 22000009
69. Hancock DB, Artigas MS, Gharib SA, Henry A, Manichaikul A, Ramasamy A, et al. Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet. 2012; 8: e1003098. doi: 10.1371/journal.pgen.1003098 PMID: 23284291
70. TCGA Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490: 61-70. doi: 10.1038/nature11412 PMID: 23000897